↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS,...
These are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that is...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Nektar Pain Drug Sends Shareholders To Rehab
Nektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for pain management and for cancer, and now its investigational drug for chronic...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire
The start of 2014 for the small and mid-cap biopharma group has been torrid. Positive exciting catalysts delivering greater-than-expected (or even in-line) results have rapidly pushed selected names...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential
One of the advantages of having wide Wall Street coverage is the ability to constantly screen even the smallest tidbits of research that is put out each day. Many times firms will put out long-winded,...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside
Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Russell 2000 Rebalance May Bring Huge Buying in Key Stocks
Typically when any major index does a rebalancing, there is a large amount of buying and selling that takes place as the index resets to the new percentage assignments for the stocks in the index. Many...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates
The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. The biggest is the possible deal between activist hedge fund manager Bill Ackman’s Pershing...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks
On the close Friday, the NYSE Arca Biotechnology Index (NYSE: BTK) is set for a rebalance. What this means is the index will be adjusted to reflect equal dollar weight allocation across the 30 stocks...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight. The two top biotech exchange traded funds...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks
On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. What this means is the index will be rebalanced to reflect reweighting allocations across the stocks that make up the...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco,...
Stocks were getting pounded on Monday after a rough Friday, on the continuation of oil and a weak Europe, even as China was closed for Chinese New Year. The stock market volatility continues, and...
View ArticleNektar Slides on Secondary Offering Pricing
Nektar Therapeutics (NASDAQ: NKTR) has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. The company plans to price its 13 million shares at $13.50, with an...
View ArticleMassive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan,...
With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little. While the volume was still lower than in non-earnings...
View ArticleTop Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina,...
Stocks were indicated to open marginally lower after a more or less inline payrolls report from the Labor Department. The Dow was indicated down 21 points and the S&P 500 was indicated down two...
View ArticleMonday’s Top Biopharma Movers
A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed to the health care sector. Much...
View ArticleTop Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan,...
24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for our readers. Some analyst reports cover stocks to buy, while other...
View ArticleTop Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti,...
Stocks were indicated to open sharply higher on Monday after the French election outcome favored Macron and therefore no threat to the EU existence. Even though this bull market is now more than eight...
View ArticleTop Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere,...
Stocks were looking for direction on Monday. Despite the Dow having crossed 22,000 for the first time, we are now more than a week with days of gains, and this is happening during what is supposed to...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s,...
Stocks closed marginally higher on Monday and were looking for direction on Tuesday. The bull market may be nine years old and stocks may be right at all-time highs, but the one trend that keeps...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink,...
After a week of stocks seeming to look for a direction, while still bumping up against all-time highs, the major stock indexes were all indicated handily lower on Thursday morning. Some of the weakness...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
50 Mid-Cap and Larger Stocks More Than Doubled in 2017
With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States and abroad. Despite a Federal...
View ArticleJefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility
One thing’s for sure: if the last two weeks haven’t left some investors a little shell-shocked, then they are lying or they sold out in front of all the selling. Truth is, most of the early selling and...
View ArticleMerck Wins Big Against Rivals in Lung Cancer Study Survival Rates
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates. Shares of Merck...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Why Nektar Therapeutics Shares Are Tumbling
Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results were...
View ArticleMonday’s Biggest Winners and Losers in the S&P 500
October 1, 2018: The S&P 500 closed up 0.4% at 2,924.81. The DJIA closed up 0.8% at 26,662.37. Separately, the Nasdaq closed flat at 8,037.30. Monday was a mixed day for the broad U.S. markets....
View ArticleNektar Therapeutics and Pfizer Team Up in Cancer Collaboration
Nektar Therapeutics (NASDAQ: NKTR) shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer Inc. (NYSE: PFE) to evaluate several combination regimens in multiple...
View ArticleTuesday’s Biggest Winners and Losers in the S&P 500
November 6, 2018: The S&P 500 closed up 0.6% at 2,755.46. The DJIA closed up 0.7% at 25,638.47. Separately, the Nasdaq closed up 0.6% at 7,375.96. Tuesday was a positive day for the broad U.S....
View ArticleMonday’s Biggest Winners and Losers in the S&P 500
November 12, 2018: The S&P 500 closed down 2.0% at 2,726.32. The DJIA closed down 2.3% at 25,388.54. Separately, the Nasdaq closed down 2.8% at 7,200.87. Monday was a down day for the broad U.S....
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE,...
The futures traded slightly higher Thursday morning as the markets digested yesterday’s upside move. Positive talk on trade and some more benign inflation data were seen as the key reasons for the...
View ArticleTuesday’s Biggest Winners and Losers in the S&P 500
January 8, 2019: The S&P 500 closed up 1.0% at 2,574.42. The DJIA closed up 1.1% at 23,787.58. Separately, the Nasdaq closed up 1.1% at 6,897.00. Tuesday was a positive day for the broad U.S....
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Activision Blizzard, ANGI, Azul, Baidu,...
Stocks have been volatile all week, but much of the losses from earlier in the week have been recovered. Stocks were indicated to open lower on Friday ahead of the weekend. What is important to keep in...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
10 Stocks Getting Crushed After Earnings
It has been a wild and volatile week in the stock market. Reactions to trade war news, interest rate scares and even earnings have all played their part in creating big winners and big losers. Some...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green...
Stocks were indicated to open lower on Tuesday with more concerns over Brexit and concerns that trade talks with China will not yield very much. The bull market is well over 10 years old, and...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit
Nektar Therapeutics (NASDAQ: NKTR) shares made a handy gain on Monday after the firm announced updated results from its first-in-human Phase 1a study of NKTR-358 for the treatment of autoimmune and...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics (NASDAQ: NKTR) shares were crushed on Wednesday after the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
This Week’s Biggest Biotech Movers
As the biotechnology group is pushing near all-time highs, this past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight. We have...
View ArticleTop Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR,...
Friday’s 600-point sell-off in the Dow Jones industrials actually knocked out the 2020 gains, but just two weeks ago the market was at all-time highs. China’s stock market is back open after the Lunar...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Altria, Beyond Meat, Chevron, Chipotle,...
The markets staged a massive comeback on Monday but sold off again on Tuesday. Wednesday’s opening bell was indicated to open up almost 600 points on the Dow Jones industrial average and almost 60...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay,...
Stocks recovered handily from their recent lows week despite Friday’s sell-off. Equity futures were negative in the wee hours of Monday, but by 8:30 or so they were up about 0.8% on the S&P 500 and...
View ArticleBioNTech, Exelixis, Foot Locker and More Tuesday Afternoon Analyst Calls
With the trading day about halfway over, the markets were somewhat mixed on Tuesday. The Nasdaq was leading the recovery from Monday’s dip. The tech and financial sectors were pushing higher, while the...
View ArticleMonday’s Top Analyst Upgrades and Downgrades: GoDaddy, Groupon, ResMed,...
Monday’s futures were somewhat mixed as traders seemed to be awaiting key economic data coming out later in the week. Although the Nasdaq and S&P 500 hit all-time highs late last week, the road...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Friday’s Top Analyst Upgrades and Downgrades: American Tower, Best Buy,...
Friday morning’s futures saw a massive jump, bunking the negative trend and four-day losing streak we saw this week. What kicked off this losing streak was a fairly negative August employment report...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Tuesday’s Top Analyst Upgrades and Downgrades: Airbnb, Canopy Growth,...
The futures were mixed on Tuesday, after another record-breaking day for the Dow Jones industrials, the S&P 500 and the Russell 2000 as they all printed fresh all-time highs. Risk-on money...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Tuesday’s Top Analyst Upgrades and Downgrades: Bloomin’ Brands, Bumble,...
The futures traded higher across the board Tuesday, after a massive Monday rally that sent all the major indexes and the transports higher. The only selling witnessed was in the Treasury bond market,...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Wednesday Afternoon’s Top Analyst Upgrades and Downgrades: Coupang, Foot...
Markets bounced back with a vengeance on Wednesday, as the Nasdaq led the charge with a gain of over 2%. At the same time, oil prices pulled back from their 14-year highs in response to markets pushing...
View ArticleMore Tuesday Analyst Upgrades and Downgrades: With Fed Rate Hike Coming,...
Markets edged higher to start off Tuesday, as West Texas Intermediate crude slid below the $100 mark. The rebound in markets also saw gold and silver prices decline as investors seem to be gaining...
View ArticleIs Earnings Optimism Enough? Analyst Upgrades and Downgrades: CSX, Gap,...
Markets edged higher to start out the week, and investors are coming out of this holiday weekend anticipating a blizzard of earnings. Less than 10% of the S&P 500 have reported, but of those that...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
The Case for a Bear Market Rally: Analysts Upgrade or Downgrade Dow, Rocket...
Markets turned lower on Tuesday, after snapping a seven-week-long losing streak for the S&P 500. Note that this was the longest losing streak for the index in over two decades. In early trading,...
View ArticleMore Inflation Ahead? Analysts Upgrade or Downgrade Coinbase, Grab, Roku and...
Markets pushed higher to start out the week, with each of the major U.S. equity indexes posting a gain. The Nasdaq led the charge higher, up around 1%, while the Dow Jones industrials and S&P 500...
View ArticleThursday’s Top Analyst Upgrades and Downgrades: Airbnb, Antero Midstream,...
The futures traded lower Thursday, after a mixed day across Wall Street that saw the S&P 500 and the Nasdaq finish the day higher, while the Dow Jones industrials closed lower. Inflation, as...
View Article
More Pages to Explore .....